Viral infections are a leading cause of myocarditis and pericarditis worldwide, conditions that
frequently coexist. Myocarditis and pericarditis were some of the early comorbidities …

Worldwide there have been over 760 million confirmed coronavirus disease 2019 (COVID-
19) cases, and over 13 billion COVID-19 vaccine doses have been administered as of April …

In the last years, major progress occurred in heart failure (HF) management. Quadruple
therapy is now mandatory for all the patients with HF with reduced ejection fraction. Whilst …

Aims To explore the incidence and potential mechanisms of oligosymptomatic myocardial
injury following COVID‐19 mRNA booster vaccination. Methods and results Hospital …

In the last years, major progress has occurred in heart failure (HF) management. The 2023
ESC focused update of the 2021 HF guidelines introduced new key recommendations …

The SARS-CoV-2 (severe acute respiratory syndrome coronavirus responsible for the
COVID-19 disease) uses the Spike proteins of its envelope for infecting target cells …

SARS-CoV-2 vaccine–associated myocarditis/myocardial injury should be evaluated in the
contexts of COVID-19 infection, other types of viral myocarditis, and other vaccine …

Abstract Background The Pfizer BioNTech COVID-19 vaccine was the first to receive
emergency authorization and approval from the FDA. Therefore, it is preferred by most …

Abstract Coronavirus disease 2019 (COVID‐19) caused by the severe acute respiratory
syndrome coronavirus 2n first appeared in Wuhan, China in 2019. Soon after, it was …

Current Opinion in Infectious Diseases Log in or Register Subscribe to journalSubscribe Get
new issue alertsGet alerts Secondary Logo Journal Logo Advanced Search Toggle navigation …